Add BrightSurf on Google Email

Researchers in Brazil discover a gene that may afford protection against COVID-19

A study on six serodiscordant couples found that women who were immune to SARS-CoV-2 had elevated expression of the gene IFIT3 compared to their male partners. This suggests that overexpression of IFIT3 may offer protection against COVID-19 by inhibiting viral replication and preventing cell invasion.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalFrontiers in Cellular and Infection Microbiology·DateJan 29, 2025

Damon Runyon Cancer Research Foundation awards $3.2 million to innovative early-career scientists

The foundation has awarded eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, including five early-career researchers with initial grants of $400,000 over two years. The awardees aim to develop novel cancer therapies using innovative approaches such as engineered skin bacteria and small molecule-boosted drug delivery.

New discovery paves the way for more resistant soybeans to combat $1.5 billion crop loss from nematode infection

Researchers have identified a key protein responsible for nematode infection in soybeans, paving the way for the development of more resistant crops. By engineering 'decoy' proteins that trick nematodes into cleaving themselves, scientists aim to reduce reliance on chemical pesticides and lower agriculture's environmental impact.

SourceAmerican Phytopathological Society·JournalMolecular Plant-Microbe Interactions·DateJan 27, 2025

KAIST uncovers the principles of gene expression regulation in cancer and cellular functions​

A KAIST research team identified core gene expression networks regulated by proteins that drive phenomena such as cancer development and tissue differentiation. The study revealed that IPMK acts as a critical transcriptional activator in these networks, enhancing SRF's protein activity.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalNucleic Acids Research·TypeObservational study·DateJan 24, 2025

Using alternative protein sources: Improving the mouthfeel of plant-based foods with fava beans

Researchers at the Leibniz Institute for Food Systems Biology found that fava bean protein nanofibrils alter the activity of receptor genes and interact with cell membranes, influencing texture perception. The study aims to develop sensorially appealing plant-based foods with improved texture.

Membrane anchor suppresses protein aggregation

Researchers have developed new models to explore the role of a membrane anchor on the folding and aggregation of PrP. Anchoring stabilizes folding and inhibits aggregation, with clumping induced by pre-formed aggregates, suggesting a potential mechanism for infectious prion diseases.

SourceRuhr-University Bochum·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 6, 2025

Programming cells: Revolutionizing genetic circuits with cutting-edge RNA tools

The team developed a Synthetic Translational Coupling Element (SynTCE) that enhances the precision and integration density of genetic circuits in synthetic biology. This allows for more efficient gene circuit integration, minimizing interference between biological parts and enabling precise control over multiple genes.

SourcePohang University of Science & Technology (POSTECH)·JournalNucleic Acids Research·DateDec 20, 2024

Study shows role of cells’ own RNA in antiviral defense

Researchers found that cellular RNA molecules help regulate antiviral signaling by activating the MAVS signalosome. This signaling pathway is crucial for coordinating immune responses against virus invasion. The study's findings suggest a potential role for RNA-based therapeutics in combating infections and autoimmune diseases.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalScience·TypeExperimental study·DateDec 19, 2024

New proteomics method enables sensitive identification of ligand-binding proteins and their binding sites in complex system

A new proteomics method, peptide-centric local stability assay (PELSA), enables the simultaneous identification of ligand-binding proteins and their binding sites in complex systems. PELSA has been shown to have superior sensitivity in target protein identifications, identifying more kinase targets than state-of-the-art methods.

SourceDalian Institute of Chemical Physics, Chinese Academy Sciences·JournalNature Methods·TypeCommentary/editorial·DateDec 11, 2024

Key breakthrough in autism: pivotal role of CPEB4 condensates revealed

A study by IRB Barcelona has identified a molecular mechanism underlying idiopathic autism, linking the lack of a specific neuronal microexon to decreased gene expression crucial for neuronal development. The discovery reveals how CPEB4 condensates regulate gene expression and highlights potential therapeutic approaches.

SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature·TypeExperimental study·DateDec 4, 2024

Unlocking the mysteries of the brain

Scientists at Purdue University have identified new molecular markers for neurodegenerative diseases by analyzing protein behavior with age. The study sheds light on how phosphorylation causes protein aggregation, a hallmark of these diseases.

SourcePurdue University·JournalMolecular & Cellular Proteomics·DateNov 22, 2024

Slow editing of protein blueprints leads to cell death

A team of researchers has identified a mechanism that interferes with the splicing process in a more subtle way, leading to cell death. The study reveals that spliceosome subunits U4, U5, and U6 are normally stabilized by protein USP39, but when mutated or absent, stability is compromised, causing incorrect connections during splicing.

SourceGoethe University Frankfurt·JournalScience·TypeExperimental study·DateNov 14, 2024

POSTECH team pioneers new cancer therapy strategy: targeting GLUT3 in regulatory T cells to supercharge anti-tumor immunity

Researchers at POSTECH have identified GLUT3 as essential for the suppressive function of regulatory T cells in tumor microenvironments, which can be targeted for cancer immunotherapy. The team's findings highlight the critical role of GLUT3 in regulating protein modifications that sustain immune suppression within tumors.

SourcePohang University of Science & Technology (POSTECH)·JournalCellular and Molecular Immunology·DateNov 12, 2024

Human proteins identified that explain inter-individual differences in functional brain connectivity

Researchers identified hundreds of brain proteins associated with inter-individual differences in functional connectivity and structural covariation. The proteins were enriched for those involved in synapses, energy metabolism, and RNA processing, providing insights into the mechanistic basis of human cognition and behavior.

SourceUniversity of Alabama at Birmingham·JournalNature Neuroscience·TypeExperimental study·DateOct 31, 2024

On the way to light-controlled medicine

Scientists have discovered a way to switch cellular activities on and off using light, opening up new possibilities for biological research and medical applications. The researchers created photoreceptors similar to those in the retina, which can be triggered by light pulses to initiate specific cellular signalling processes.

SourcePaul Scherrer Institute·JournalNature Communications·TypeExperimental study·DateOct 24, 2024

Cellular liquid droplets can cut membranes

Scientists have found that biomolecular condensates can cross membranes without specialized cutting proteins, a process called wetting, which is essential for plant survival. The study shows that these liquid droplets can exert large capillary forces on membranes, cutting them in two and enabling material exchange between cell parts.

SourceUniversity of Cologne·JournalNature·TypeExperimental study·DateOct 14, 2024

Toxic protein may contribute to ALS development

A new study found that toxic SOD1 protein trimers interact with various proteins in different tissues, contributing to cellular dysfunction and degeneration in ALS. Septin-7 is identified as a potential therapeutic target, potentially slowing or disrupting ALS progression.

SourcePenn State·JournalStructure·TypeExperimental study·DateOct 14, 2024